- /
- Supported exchanges
- / US
- / DBVT.NASDAQ
DBV Technologies (DBVT NASDAQ) stock market data APIs
DBV Technologies Financial Data Overview
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow's milk protein allergy and eosinophilic esophagitis. The company's earlier stage research programs include celiac disease. In addition, the company develops Viaskin technology platform, a platform to potentially treat food allergy. It has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Châtillon, France.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with DBV Technologies (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get DBV Technologies data using free add-ons & libraries
Get DBV Technologies Fundamental Data
DBV Technologies Fundamental data includes:
- Net Revenue: 3 736 K
- EBITDA: -205 862 000
- Earnings Per Share: -3
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-10-28
- EPS/Forecast: -0.6
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
DBV Technologies News
New
European Equities Traded in the US as American Depositary Receipts Decline Slightly in Tuesday Trading
European equities traded in the US as American depositary receipts were tracking slightly lower late Keep reading this article with Yahoo Finance Plus Silver Upgrade to Silver Silver Premium news ...
DBV expects cash runway into Q3 2027 as it advances sequential FDA reviews for VIASKIN Peanut BLAs
Earnings Call Insights: DBV Technologies (DBVT) Q3 2026 MANAGEMENT VIEW * "The highlight of the quarter was the filing of our BLA in 4 to 7-year olds" (CEO & Director Daniel Tassé). * "In tande...
European Equities Traded in the US as American Depositary Receipts Steady in Wednesday Trading
European equities traded in the US as American depositary receipts were little changed around 1,893. PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading
European equities traded in the US as American depositary receipts were tracking lower late Tuesday PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscrip...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.